Company Profile

CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE624.35-5.55 (-0.88 % )
PREV CLOSE (Rs.) 629.90
OPEN PRICE (Rs.) 633.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 181770
TODAY'S LOW / HIGH (Rs.)622.00 633.95
52 WK LOW / HIGH (Rs.)347.05 673.7
NSE623.55 -6.5 (-1.03 % )
PREV CLOSE(Rs.) 630.05
OPEN PRICE (Rs.) 632.70
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 623.55 (1342 )
VOLUME 3043828
TODAY'S LOW / HIGH(Rs.) 621.40 633.20
52 WK LOW / HIGH (Rs.)347.05 673.7

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.01
Dividend Yield(%) 0.56
TTM EPS (Rs.) 14.42
P/E Ratio 43.30
Book Value (Rs.) 118.38
Face Value (Rs.) 1
MCap (Rs. in Mn) 639173.69
Price/Earning (TTM) 33.16
Price/Sales (TTM) 8.59
Price/Book (MRQ) 5.27
PAT Margin (%) 20.63
ROCE (%) 13.72
Incorporation Year : 1995

Management Info :

Pankaj R Patel - Chairman Sharvil P Patel - Managing Director

Registered Office :

Address : Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone : 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Registrar's Details : Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX
NEWS More
21Jun06-21-2021$Cadila Healthcare signs agreement to extend tenure of JVA with Bayer Cadila Healthcare signs agre

Cadila Healthcare has signed an agreement to extend the tenure of the joint venture agreement (JVA) with Bayer (South East Asia) PTE, one of the companies of the Bayer Group, for a period of three years. The amendment is to extend the term of the JVA for a period of three years till May 1, 2024. The company believes that the extension of the JVA would be beneficial considering the prospects of the growth of the JV over next three years.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Cadila Healthcare has signed an agreement to extend the tenure..
21Jun06-21-2021$Cadila Healthcare gains on signing agreement to extend tenure of JVA with Bayer Cadila Healthcare gains on s

Cadila Healthcare is currently trading at Rs. 623.50, up by 3.30 points or 0.53% from its previous closing of Rs. 620.20 on the BSE.

The scrip opened at Rs. 620.95 and has touched a high and low of Rs. 627.65 and Rs. 613.75 respectively. So far 93274 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 673.70 on 12-May-2021 and a 52 week low of Rs. 347.05 on 01-Jul-2020.

Last one week high and low of the scrip stood at Rs. 668.00 and Rs. 603.60 respectively. The current market cap of the company is Rs. 63861.06 crore.

The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 16.53% and 8.40% respectively.

Cadila Healthcare has signed an agreement to extend the tenure of the joint venture agreement (JVA) with Bayer (South East Asia) PTE, one of the companies of the Bayer Group, for a period of three years. The amendment is to extend the term of the JVA for a period of three years till May 1, 2024. The company believes that the extension of the JVA would be beneficial considering the prospects of the growth of the JV over next three years.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Cadila Healthcare is currently trading at Rs. 623.50, up by 3.3..
21Jun06-21-2021$Cadila Healthcare informs about disclosure Cadila Healthcare informs ab
Cadila Healthcare has informed that the Company, as a joint venture partner, has signed an agreement to extend the tenure of the joint venture agreement (JVA) with Bayer (South East Asia) PTE, one of the companies of the Bayer Group, for a period of three years. Additional disclosures, with regard to extension of the JVA, as required under the Listing Regulations read with SEBI Circular No. CIR/CFO/CMD/4/2015 dated September 9, 2015 are given in Annexure 1 to this letter.

The above information is a part of company’s filings submitted to BSE.

Cadila Healthcare has informed that the Company, as a joint ven..
14Jun06-14-2021$Cadila Healthcare informs about press release Cadila Healthcare informs ab

Cadila Healthcare has informed that it has enclosed a copy of press release dated June 14, 2021 titled ‘Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets’. Bring this news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.


Cadila Healthcare has informed that it has enclosed a copy of p..
14Jun06-14-2021$Cadila Healthcare informs about transcript of 1st EGM Cadila Healthcare informs ab

Cadila Healthcare has informed that it has attached the transcript of the 1st Extra Ordinary General Meeting (EGM) of the Financial Year 2021-2022 of the members of the Company held on June 11, 2021. The same is also posted on the website of the Company www.zyduscadila.com.

The above information is a part of company’s filings submitted to BSE.

Cadila Healthcare has informed that it has attached the transcr..
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit464714762
Gross Profit 4418 16885
Operating Profit 577323980
Net Sales 2018877904
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Pfizer (BSE)
 5586.35 (1.67%)
M.Cap ( in Cr)
25556.28
Sanofi India (BSE)
 7734.25 (0.52%)
M.Cap ( in Cr)
17814.19
Medicamen Biotech (BSE)
 555.45 (4.62%)
M.Cap ( in Cr)
671.97
JB Chem & Pharma (BSE)
 1545.85 (1.17%)
M.Cap ( in Cr)
11940.08
Bajaj Healthcare (BSE)
 705.05 (2.08%)
M.Cap ( in Cr)
972.91
Shareholding Pattern More
NON-INSTITUTION 8.4 %
PROMOTERS 74.88 %
MUTUAL FUNDS/UTI 6.41 %
FI/BANKS/INSURANCE 4.71 %
GOVERNMENT 0.19 %
FII 0 %
F & O Quotes